Benjamin Oakes from Scribe Therapeutics shares how exciting advancements in CRISPR-based gene and epigenetic editing therapies impact the future of cardiovascular and cardiometabolic disease management. Summary Benjamin Oakes highlights the transformative potential of CRISPR technology, Read More
Tags :therapies
A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the parasite responsible for the deadliest form of human malaria, that could make novel, highly targeted anti-malarial therapies Read More